Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: AMPA receptor agonists - RespireRx

Drug Profile

Research programme: AMPA receptor agonists - RespireRx

Alternative Names: Ampakines; CX 929; CX1501; CX1763; CX1796; CX1837; CX1846; CX1942; CX2007; CX2076; CX516; CX614; CX707

Latest Information Update: 30 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cortex Pharmaceuticals
  • Developer Cortex Pharmaceuticals; RespireRx Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action AMPA receptor agonists; Brain derived neurotrophic factor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Respiratory insufficiency
  • No development reported Alzheimer's disease; Anxiety disorders; Attention-deficit hyperactivity disorder; Fragile X syndrome; Huntington's disease; Major depressive disorder; Mild cognitive impairment; Parkinson's disease; Rett syndrome; Schizophrenia; Sleep apnoea syndrome; Spinal cord injuries; Stroke
  • Discontinued Autistic disorder; Chronic brain damage

Most Recent Events

  • 28 Apr 2018 No recent reports of development identified for preclinical development in Spinal-cord-injuries in USA (PO)
  • 31 Dec 2017 CX 1942 is still in preclinical trials for Respiratory insufficiency in USA
  • 01 Apr 2016 Preclinical development is ongoing for Spinal cord injuries in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top